New Zealand’s strategy to improve the lives and uphold the rights of disabled people will be refreshed using an innovative new approach, Disability Issues Minister Louise Upston has announced.
“The current 10-year strategy ends in 2026 and has provided a valuable focus for disability work during the past decade,” Louise Upston says.
“While progress has been made, there is clearly more to do.
New Zealand’s pharmaceutical sector is cautiously optimistic over the industry being granted an exemption from US President Donald Trump’s tariffs.
The legislation will give the health minister the power to approve, reject or transfer medication applications
A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its producer hoping to make it accessible “as soon as possible”.
HEALTH SERVICES AND SYSTEMS
EQUITY
Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI
